Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect

John A. Eisman, Henry G. Bone, David J. Hosking, Michael R. McClung, Ian R. Reid, Rene Rizzoli, Heinrich Resch, Nadia Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Romana Petrovic, Arthur C. Santora, B. Avery Ince, Antonio Lombardi

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)242-251
JournalJournal of Bone and Mineral Research
Volume26
Issue number2
DOIs
Publication statusPublished - Feb 2011

Keywords

  • BONE MINERAL DENSITY
  • CATHEPSIN K
  • CLINICAL TRIAL
  • ODANACATIB
  • OSTEOPOROSIS
  • PHASE 2B
  • POSTMENOPAUSAL WOMEN

Cite this

Eisman, J. A., Bone, H. G., Hosking, D. J., McClung, M. R., Reid, I. R., Rizzoli, R., Resch, H., Verbruggen, N., Hustad, C. M., DaSilva, C., Petrovic, R., Santora, A. C., Ince, B. A., & Lombardi, A. (2011). Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect. Journal of Bone and Mineral Research, 26(2), 242-251. https://doi.org/10.1002/jbmr.212